Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Clinical and Vaccine Immunology : CVI|May 15, 2015
Cross-Reactive Epitopes in Borrelia burgdorferi p66Paul M Arnaboldi, Raymond J DattwylerClinical and Vaccine Immunology : CVI|August 15, 2014
Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North AmericaPaul M Arnaboldi, Mariya Sambir, Raymond J DattwylerEbiomedicine|May 2, 2017
Borrelia burgdorferi-specific IgA in Lyme DiseaseChristina D'Arco, Raymond J Dattwyler, Paul M ArnaboldiVaccine|February 3, 2021
Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infectionChristina D'Arco, Alison A McCormick, Paul M ArnaboldiJournal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Mucosal B cell deficiency in IgA-/- mice abrogates the development of allergic lung inflammationPaul M Arnaboldi, Melissa J Behr, Dennis W MetzgerMsphere|May 3, 2019
Linear B Cell Epitopes Derived from the Multifunctional Surface Lipoprotein BBK32 as Targets for the Serodiagnosis of Lyme DiseaseChristina Toumanios, Lauren Prisco, Raymond J Dattwyler, et al.Pathogens (Basel, Switzerland)|August 26, 2022
Linear Peptide Epitopes Derived from ErpP, p35, and FlaB in the Serodiagnosis of Lyme DiseasePaul M Arnaboldi, Adiya S Katseff, Mariya Sambir, et al.Clinical and Vaccine Immunology : CVI|March 14, 2014
Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme diseaseGiacomo Signorino, Paul M Arnaboldi, Mary M Petzke, et al.Clinical and Vaccine Immunology : CVI|February 1, 2013
Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme diseasePaul M Arnaboldi, Rudra Seedarnee, Mariya Sambir, et al.Pathogens (Basel, Switzerland)|February 23, 2024
Immune Mediators Important for a Protective Secondary Response to Babesia microtiJoseph Conti, Thomas Gagliardi, Paul M Arnaboldi, et al.Pageof 3